← Back to Search

N/A

Passive Descent vs Pushing for Labor Management in Obese Women

N/A
Waitlist Available
Led By Alisse Hauspurg, MD
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Gestational age of 37 0/7 weeks and greater
Must not have
No regional anesthesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at delivery
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating whether or not passive descent (allowing the baby to descend on its own without the mother pushing) could improve the spontaneous vaginal delivery rate in nulliparous, obese women.

Who is the study for?
This trial is for obese women with a BMI of 30 or higher who are pregnant for the first time, at least 37 weeks along, and have a single baby. They must be receiving regional anesthesia during labor. Women with lower BMIs, less than full-term pregnancies, fever before the second stage of labor, no regional anesthesia, previous deliveries after 20 weeks gestation, multiple babies in the womb or severe fetal anomalies cannot participate.
What is being tested?
The study is testing two different methods to manage labor in obese women having their first child: 'Passive Descent' where they wait ninety minutes before pushing versus 'Immediate Pushing' when entering the second stage of labor. The goal is to see if passive descent increases spontaneous vaginal delivery rates.
What are the potential side effects?
While not explicitly listed as side effects in this context since it's about management techniques rather than medication or surgery; potential risks may include fatigue from prolonged labor and possible complications from delayed active pushing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 37 weeks pregnant.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not had regional anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at delivery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Neonatal Outcomes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Passive DescentExperimental Treatment1 Intervention
Patient's will wait 90 minutes prior to begin pushing
Group II: Immediate PushingActive Control1 Intervention
Patient's will begin to push when they are determined to be completely dilated.

Find a Location

Who is running the clinical trial?

Women and Infants Hospital of Rhode IslandLead Sponsor
113 Previous Clinical Trials
39,770 Total Patients Enrolled
Alisse Hauspurg, MDPrincipal InvestigatorWomen & Infant's Hospital
2 Previous Clinical Trials
258 Total Patients Enrolled
Erika Werner, MDStudy DirectorWomen & Infant's Hospital
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Passive Descent (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT02080429 — N/A
Delayed pushing Research Study Groups: Immediate Pushing, Passive Descent
Delayed pushing Clinical Trial 2023: Passive Descent Highlights & Side Effects. Trial Name: NCT02080429 — N/A
Passive Descent (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02080429 — N/A
~360 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top